GGrantIndex
Sort

51,593 grants matching hepatitis

Genetic Determinants of Weight Loss and Resolution of Co-Morbidities

$492,572
Glenn S Gerhard · Geisinger Clinic · R01 · FY2011 · DK

Role of CREG1 in metabolic homeostasis

$492,547
Shaohua Li · Rutgers Biomedical And Health Sciences · R01 · FY2023 · DK

TNF Alpha and Recovery from Alcoholic Liver Injury

$492,507
Anna Mae Elizabeth Diehl · Duke University · R01 · FY2021 · AA

Defining a Protective Ebola Vaccine in Non-Human Primates

$492,487
Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2016 · AI

Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities

$492,440
Lloyd A Goldsamt · New York University · R01 · FY2016 · DA

Glutamine synthetase in beta-catenin driven hepatocellular carcinoma

$492,434
Wei-Xing Zong · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Innovative In Vivo-like Model for Vascular Tissue Engineering

$492,410
Joerg C Gerlach · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL

A new, rapidly dissolving and thermally stable dry powder Hepatitis-B vaccine

$492,386
Stephen P Cape · Aktiv-Dry, Llc · R44 · FY2012 · AI

Mechanisms linking the Branched-Chain alpha-Keto Acid regulatory network to the pathogenesis of NASH

$492,365
Phillip J White · Duke University · R01 · FY2025 · DK

Simultaneous Assay for Multiple Pathogens in Blood (SAMP-B)

$492,274
Gao Chen · Maxwell Sensors, Inc. · R44 · FY2013 · HL

Aldehydes in Alcohol-Induced Organ Injury

$492,235
Zhanxiang Zhou · University Of North Carolina Greensboro · R01 · FY2023 · AA

Mice Humanized with Hepatocytes and iPS Cells from Patients with Metabolic Diseas

$492,225
Stephen C Strom · University Of Pittsburgh At Pittsburgh · RC1 · FY2010 · DK

HEPATIC CARCINOGENESIS INDUCED BY HEPATITIS B VIRUS PreS2 MUTANT

$492,192
Tien-Sze Benedict Yen · University Of Southern California · P01 · FY2010 · CA

Glutamine synthetase in beta-catenin driven hepatocellular carcinoma

$492,130
Wei-Xing Zong · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA

Gene Therapy of Mucopolysaccharidosis VII

$492,098
Mark E Haskins · University Of Pennsylvania · R01 · FY2009 · DK

CLINICAL TRIAL: PHASE I EVALUATION OF A LIVE ATTENUATED DEN4 VACCINE

$492,094
Beth Diane Kirkpatrick · University Of Vermont & St Agric College · M01 · FY2010 · RR

CELLULAR MECHANISMS OF INSULIN RESISTANCE IN HUMANS

$492,077
Yale University · R01 · FY2002 · DK

NOVEL APPROACHES FOR REGULATION OF IGF-1 LEVELS THROUGHOUT THE LIFESPAN

$492,047
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2014 · AG

Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer

$492,020
Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Primary human trophoblasts and the transfer of viral resistance

$492,001
Yoel Sadovsky · Magee-Women'S Res Inst And Foundation · R01 · FY2012 · HD

A splicing-generated protein of hepatitis B virus in chronic viral infection

$492,000
Shuping Tong · Rhode Island Hospital · R56 · FY2024 · AI

Molecular Basis of a New Form of Hyperinsulinism

$491,978
Charles Alfred Stanley · Children'S Hosp Of Philadelphia · R01 · FY2010 · DK

Transcriptional and non-transcriptional functions of IRF3 in ALD

$491,942
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · AA

HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA

$491,862
Charles E. Rogler · Albert Einstein College Of Medicine · R01 · FY2011 · CA

Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity

$491,860
Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2016 · GM